<DOC>
	<DOCNO>NCT02767310</DOCNO>
	<brief_summary>The purpose study determine bioequivalence Rosuvastatin/ Verisfield 20 mg film-coated tablet Crestor™/ AstraZeneca 20 mg film-coated tablet .</brief_summary>
	<brief_title>Study Determine Bioequivalence Two Products Containing Rosuvastatin ( 20 mg/Tablet )</brief_title>
	<detailed_description>This study aim compare absorption disposition kinetics two product contain rosuvastatin fasting condition . These product : Rosuvastatin/ Verisfield 20 mg film-coated tablet , Test product manufacture HELP S.A. , Greece Crestor™/ AstraZeneca 20 mg film-coated tablet , Reference product manufacture AstraZeneca , UK . The bioequivalence single 20 mg dose product assess compare pharmacokinetic parameter derive plasma concentration-time profile rosuvastatin .</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Willingness provide inform consent participate study . Comprehension nature purpose study willingness comply requirement entire procedure . Healthy adult , human Indian volunteer within age range 18 45 year ( inclusive ) . Body Mass Index ( BMI ) ≥ 18.50 kg/m2 ≤ 30.00 kg/m2 . Hemoglobin : ≥12.0 gm % male ≥11.5 gm % female . Absence disease marker HIV I &amp; II , HBsAg , HCVAb P24 antigen test . Females childbearing age must practice acceptable form birth control least six month screen , unless bilateral oophorectomy tubal ligation male partner vasectomy . Females childbearing age agree use acceptable form birth control study drug wash body , i.e . least 14 day last dosing , unless bilateral oophorectomy tubal ligation male partner vasectomy . Absence significant disease clinically significant abnormal laboratory value laboratory evaluation . Absence diseases medical history physical examination screening . Have normal 12lead ECG one abnormality consider clinically insignificant . Have normal chest Xray ( P. A. view ) . Non smoker ( since last six month ) Negative serum βHCG time screen ( female ) History / evidence allergy hypersensitivity rosuvastatin excipients drug . Any major illness within last three month significant ongoing chronic medical illness . History active liver kidney disease . History active deep vein thrombosis thromboembolic disorder . History breast cancer , endometrial cancer estrogendependent neoplasia , endometriosis undiagnosed vaginal bleeding ( female ) . History drug abuse ( include barbiturate , benzodiazepine , opioids , cocaine , cannabinoids amphetamine etc . ) within last three month . History neuropsychiatric disease . History hypothyroidism . Personal family history hereditary muscular disorder . History myopathy . History myalgia . History rhabdomyolysis . History alcohol abuse . History proteinuria . Asian population ( except Indian ) . History interstitial lung disease . History current gastrointestinal disease influence drug absorption . History alcoholism ( two year ) , moderate drinker ( three drink per day ) . Participation clinical trial within last three month . History difficulty donate blood difficulty accessibility vein leave right arm . Donation blood ( one unit 350 mL ) within last three month . Use prescription drug therapy within last two week counter ( OTC ) drug herbal product within last one week . Pregnant woman . Breast feeding woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>two rosuvastatin-containing product</keyword>
</DOC>